Trial intelligence / Profile preview

Oral Ondansetron Strips for Post-Spinal Shivering

NCT07088601Phase 4Not yet recruiting

Sponsor
Cairo University
Start
Aug 2025
Primary completion
Dec 2025
Modality
Small Molecules
01

Overview

Phase 4, randomised, double-blind trial in post-spinal shivering (PSS) comparing Ondansetron Group with Placebo Group (2 arms). Primary endpoint: Incidence of shivering. Planned start Aug 2025; status: not yet recruiting.

02

Drugs

ondansetron
03

Conditions

post-spinal shivering (PSS)

Beyond the preview

Go deeper on NCT07088601.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07088601.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call